3 completed. 3 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 3 |
| Phase 2 | 1 | Completed 1 |
Follow NmCV-5 vaccine: new trials by email Literature Review of NmCV-5 vaccine trials Research Report on NmCV-5 vaccine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Meningococcal Serogroup ACYWX Conjugate Vaccine in Comparison With MenACWY-TT Conjugate Vaccine NmCV-5, MenACWY-TT - Meningitis | Phase 3 | Completed | Emory University | 1325 | 2022-03-24 | 2026-03-31 |
| Study to Evaluate the Lot to Lot Consistency of SIIPL Meningococcal ACYWX Conjugate Vaccine and to Compare Its Safety and Immunogenicity With That of Licensed Meningococcal ACWY Vaccine Menactra® in Healthy Individuals 18-85 Years of Age NmCV-5, Menactra - Vaccine for Meningococcal Disease | Phase 2 / Phase 3 | Completed | Serum Institute of India Pvt. Ltd. | 1640 | 2019-12-27 | 2021-09-08 |
| Study to Assess Immunegnicity & Safety of Pentavalent Meningococcal Vaccine (NmCV-5) NmCV-5, Menactra - Meningococcal Meningitis | Phase 3 | Completed | Serum Institute of India Pvt. Ltd. | 1800 | 2019-08-20 | 2021-07-27 |
Meningitis (1) · Meningitis, Meningococcal (1)
Serum Institute of India Pvt. Ltd. (2) · Emory University (1)
Mali (2) · India (1) · The Gambia (1)
Dr Prasad Kulkarni, MD (1) · Karen Kotloff, MD (1) · Wilbur Chen, MD, MS (1)
PMID 37224196, PMID 37224203, PMID 37256991, PMID 37256992, PMID 39521012, PMID 40086461
UM1AI148689 (1)